Christopher J. Mcdermott

Regent Court, 30 Regent Street
Sheffield, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 235 publications

Repairing the Amyotrophic Lateral Sclerosis Trial Credibility Gap.

Repairing the Amyotrophic Lateral Sclerosis Trial Credibility Gap.

Journal: Neurology

Published: September 02, 2026

The EQ-5D-5L in amyotrophic lateral sclerosis: an international longitudinal exploration as part of ALS-CarE.

The EQ-5D-5L in amyotrophic lateral sclerosis: an international longitudinal exploration as part of ALS-CarE.

Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration

Published: August 13, 2026

ALSUntangled #84 - ivermectin.

ALSUntangled #84 - ivermectin.

Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration

Published: August 06, 2026

Systematic review of outcome measures in facioscapulohumeral dystrophy (FSHD): validated, usable, and feasible tools for assessing function, performance, and strength.

Systematic review of outcome measures in facioscapulohumeral dystrophy (FSHD): validated, usable, and feasible tools for assessing function, performance, and strength.

Journal: Neuromuscular disorders : NMD

Published: April 18, 2026

Co-Designing a Care Coordination Intervention for People With Motor Neuron Disease: Protocol for a Mixed Methods Study.

Co-Designing a Care Coordination Intervention for People With Motor Neuron Disease: Protocol for a Mixed Methods Study.

Journal: JMIR research protocols

Published: April 08, 2026

Developing an implementation strategy to scale a community-based football intervention for Men's health: an implementation science study.

Developing an implementation strategy to scale a community-based football intervention for Men's health: an implementation science study.

Journal: Frontiers in health services

Published: March 20, 2026

ALS untangled #83: clenbuterol.

ALS untangled #83: clenbuterol.

Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration

Published: March 08, 2026

"What about me? I'm supposed to be … superhuman?": exploring staff perspectives on how to deliver high quality psychological care for people living with amyotrophic lateral sclerosis.

"What about me? I'm supposed to be … superhuman?": exploring staff perspectives on how to deliver high quality psychological care for people living with amyotrophic lateral sclerosis.

Journal: Neurodegenerative disease management

Published: March 06, 2026

ALSUntangled #82: N-acetylcysteine.

ALSUntangled #82: N-acetylcysteine.

Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration

Published: March 04, 2026

Patient and caregiver attitudes to cognitive and behavioral testing in Amyotrophic Lateral Sclerosis.

Patient and caregiver attitudes to cognitive and behavioral testing in Amyotrophic Lateral Sclerosis.

Journal: Neurodegenerative disease management

Published: February 28, 2026

The Emotional Experiences of Healthcare Professionals Working in Amyotrophic Lateral Sclerosis: A Systematic Review.

The Emotional Experiences of Healthcare Professionals Working in Amyotrophic Lateral Sclerosis: A Systematic Review.

Journal: Muscle & nerve

Published: February 24, 2026

Timing of communication and technology control support in ALS - a systematic review.

Timing of communication and technology control support in ALS - a systematic review.

Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration

Published: February 20, 2026

Showing 1-12 of 235

Last Updated: 09/26/2026